SEC recommends Phase-1 clinical trials of RIL's Covid vaccine candidate

Friday, August 27, 2021

SEC recommends Phase-1 clinical trials of RIL's Covid vaccine candidate

Posted By: Unknown August 27, 2021 Leave a Reply
The trials will be done at 10 sites in India, including centres in Tamil Nadu, Andhra Pradesh, Maharashtra and Delhi

from Latest News https://ift.tt/3jletX9
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

0 comments: